Free Trial

Cencora (COR) Competitors

Cencora logo
$285.46 +7.06 (+2.53%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$285.20 -0.26 (-0.09%)
As of 08/8/2025 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, LH, NTRA, and ICLR

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Labcorp (LH), Natera (NTRA), and Icon (ICLR). These companies are all part of the "medical" sector.

Cencora vs. Its Competitors

Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Elevance Health has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500.

In the previous week, Cencora had 27 more articles in the media than Elevance Health. MarketBeat recorded 60 mentions for Cencora and 33 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.39 beat Cencora's score of 1.13 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
27 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cencora
33 Very Positive mention(s)
6 Positive mention(s)
15 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 10.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.83% 17.59% 6.36%
Cencora 0.60%267.36%4.31%

Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.3%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cencora has increased its dividend for 15 consecutive years.

Elevance Health currently has a consensus price target of $418.19, suggesting a potential upside of 42.08%. Cencora has a consensus price target of $309.83, suggesting a potential upside of 8.54%. Given Elevance Health's higher possible upside, analysts clearly believe Elevance Health is more favorable than Cencora.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.67
Cencora
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$189.25B0.35$5.98B$23.5012.52
Cencora$293.96B0.19$1.51B$9.7229.37

Summary

Elevance Health and Cencora tied by winning 9 of the 18 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$55.26B$7.33B$5.53B$20.74B
Dividend Yield0.77%2.75%4.60%3.66%
P/E Ratio29.3765.5630.0628.08
Price / Sales0.1930.78448.6455.89
Price / Cash14.3425.7836.7723.06
Price / Book25.0417.878.194.33
Net Income$1.51B$243.10M$3.27B$994.81M
7 Day Performance-0.99%2.42%6.14%1.97%
1 Month Performance-3.99%-4.08%0.07%-1.60%
1 Year Performance20.06%18.47%36.43%14.35%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.2212 of 5 stars
$285.46
+2.5%
$309.83
+8.5%
+20.1%$55.26B$293.96B29.3746,000News Coverage
Positive News
Earnings Report
Dividend Announcement
Analyst Revision
ELV
Elevance Health
4.9043 of 5 stars
$279.75
+1.9%
$418.19
+49.5%
-44.7%$63.00B$177.01B11.91104,200News Coverage
Positive News
MCK
McKesson
4.6405 of 5 stars
$707.85
+1.3%
$710.17
+0.3%
+23.3%$88.63B$359.05B27.4245,000News Coverage
Positive News
Earnings Report
Analyst Forecast
Analyst Revision
CAH
Cardinal Health
4.6457 of 5 stars
$158.27
+1.5%
$158.07
-0.1%
+56.4%$37.83B$226.83B24.7348,900News Coverage
Positive News
Upcoming Earnings
HSIC
Henry Schein
4.0953 of 5 stars
$69.43
+2.1%
$78.08
+12.5%
-4.4%$8.44B$12.67B21.6625,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
OMI
Owens & Minor
4.8057 of 5 stars
$6.80
+3.5%
$11.60
+70.6%
-53.5%$528.42M$10.72B-1.4423,200News Coverage
Upcoming Earnings
Analyst Upgrade
Options Volume
Gap Up
DHR
Danaher
4.8468 of 5 stars
$196.27
-0.4%
$247.61
+26.2%
-25.1%$140.53B$23.88B41.7663,000News Coverage
Positive News
CVS
CVS Health
4.9985 of 5 stars
$62.31
-0.3%
$75.39
+21.0%
+14.7%$79.11B$372.81B17.42300,000Positive News
LH
Labcorp
4.6212 of 5 stars
$265.50
+1.5%
$289.58
+9.1%
+17.5%$22.22B$13.01B29.3170,000Positive News
NTRA
Natera
3.5663 of 5 stars
$133.92
-0.5%
$183.76
+37.2%
+32.6%$18.32B$1.70B-91.294,434Trending News
Earnings Report
Analyst Forecast
Insider Trade
Gap Up
ICLR
Icon
4.17 of 5 stars
$166.70
+0.2%
$219.54
+31.7%
-49.4%$13.40B$8.09B17.0841,900

Related Companies and Tools


This page (NYSE:COR) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners